PODDINSULET CORP

Nasdaq insulet.com


$ 160.95 $ -4.88 (-2.94 %)    

Monday, 13-May-2024 15:59:53 EDT
QQQ $ 442.84 $ 1.02 (0.23 %)
DIA $ 394.52 $ -0.72 (-0.18 %)
SPY $ 520.61 $ 0.07 (0.01 %)
TLT $ 90.36 $ 0.23 (0.26 %)
GLD $ 216.28 $ -2.45 (-1.12 %)
$ 161.02
$ 166.63
$ 0.00 x 0
$ 160.91 x 100
$ 160.29 - $ 170.14
$ 125.82 - $ 331.65
1,697,681
na
11.87B
$ 1.11
$ 50.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-23-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-07-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 04-29-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 04-30-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-equal-weight-on-insulet-lowers-price-target-to-200

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and lowers the price target from $213 to $200.

 canaccord-genuity-maintains-buy-on-insulet-raises-price-target-to-234

Canaccord Genuity analyst Kyle Rose maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $226 to $234.

 stocks-pause-on-dismal-consumer-confidence-yields-dollar-rise-as-inflation-expectations-kick-higher-bitcoin-sinks-whats-driving-markets-friday-corrected

Editor’s note: This story has been updated to correct an error in the price action of Charter Communications stock.

 raymond-james-maintains-outperform-on-insulet-lowers-price-target-to-213

Raymond James analyst Jayson Bedford maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $218...

 jefferies-maintains-buy-on-insulet-raises-price-target-to-260

Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $255 to $260.

 insulet-expects-q2-revenue-growth-of-15-18-raising-its-expected-revenue-growth-from-12-17-to-14-18

2024 Outlook:Revenue Guidance (in constant currency):For the year ending December 31, 2024, the Company is raising its expected...

 insulet-q1-adj-073-beats-039-estimate-sales-44170m-beat-42405m-estimate

Insulet (NASDAQ:PODD) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.39 by 87.1...

 wolfe-research-upgrades-insulet-to-outperform-announces-200-price-target

Wolfe Research analyst Mike Polark upgrades Insulet (NASDAQ:PODD) from Peer Perform to Outperform and announces $200 price t...

 top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-heres-what-investors-think-about-them-wall-street-vs-reddit

Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed.

 on-thursday-february-22-insulet-gave-q1-2024-revenue-growth-guidance-of-17-20-for-fy24-the-company-expects-revenue-growth-in-the-range-of-12-17

2024 Outlook:Revenue Guidance (in constant currency):Guidance for the first quarter and full year 2024 reflects an estimated $2...

 surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, I...

 barclays-maintains-equal-weight-on-insulet-lowers-price-target-to-213

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and lowers the price target from $214 to $213.

 jp-morgan-maintains-overweight-on-insulet-raises-price-target-to-225

JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $190 to $...

 nasdaq-sp-500-set-for-mixed-open-after-nvidia-euphoria-analyst-picks-major-market-catalyst-this-year-if-there-are-no-rate-cuts

After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday ref...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION